Glenmark Pharmaceuticals Inc., USA has recalled 36 bottles of Northstar Rx brand Desmopressin Acetate (0.2 mg) tablets in 100-count bottles. This recall was issued because the manufacturing process did not meet specific quality standards, known as Current Good Manufacturing Practice (CGMP) deviations. No incidents or injuries related to this product have been reported.
The deviations in quality standards could potentially affect the consistency or quality of the medication. This drug is used to treat specific medical conditions such as diabetes insipidus and bedwetting; a failure in product quality could potentially impact its effectiveness.
You have 2 options:
Manufactured for Northstar Rx LLC, Memphis, TN; Manufactured by Glenmark Pharmaceuticals Ltd., India. Recall # D-1171-2022.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.